已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma

NFAT公司 嵌合抗原受体 癌症研究 白细胞介素15 生物 免疫学 T细胞 化学 白细胞介素 免疫系统 医学 细胞因子 移植 内科学 钙调神经磷酸酶
作者
Reona Okada,Jeyshka M. Reyes‐González,Constanza Rodríguez,Taisuke Kondo,Jangsuk Oh,Ming Sun,Michael C. Kelly,Ling Zhang,James L. Gulley,Jack F. Shern,Mitchell Ho,Christian S. Hinrichs,Naomi N. Taylor,Xiyuan Zhang,Rosa Nguyen
出处
期刊:Cancer immunology research [American Association for Cancer Research]
卷期号:13 (9): 1363-1373 被引量:15
标识
DOI:10.1158/2326-6066.cir-24-0975
摘要

Neuroblastoma is a highly aggressive childhood solid tumor with poor outcomes. Chimeric antigen receptor (CAR) T cells have shown limited efficacy in neuroblastoma, with the best outcomes reported in patients with a low tumor burden, highlighting the need for further CAR optimization. One approach to addressing the high tumor burden involves engineering CAR T cells to release or express transgenic cytokines. However, its systemic toxicity remains an important therapeutic challenge. In this study, we evaluated the efficacy of IL15- and IL21-enhanced glypican 2 (GPC2)-targeted CAR T cells (GPC2-CAR T cells) in targeting high-burden neuroblastoma. Three strategies for expressing the cytokines were evaluated: constitutive secretion (GPC2-CAR + sol.IL15.IL21), constitutive membrane-tethered expression (GPC2-CAR + teth.IL15.IL21), and NFAT-inducible membrane-tethered expression (GPC2-CAR + NFAT.IL15.IL21). Engineered GPC2-CAR T cells were tested in vitro and in vivo using high neuroblastoma burden xenograft models. Additionally, single-cell RNA sequencing was used to profile the effector cells in the tumor microenvironment. All three versions of GPC2-CAR T cells significantly enhanced killing against a high neuroblastoma burden, both in vitro and in vivo, relative to control GPC2-CAR T cells. Mice treated with GPC2-CAR + NFAT.IL15.IL21 exhibited significantly lower anorexia-associated morbidity/mortality. Supporting these data, tumor-infiltrating GPC2-CAR + NFAT.IL15.IL21 developed an immunosuppressive transcriptional profile upon tumor regression, leading to prolonged survival in treated mice. In contrast, GPC2-CAR + teth.IL15.IL21 maintained a proinflammatory transcriptional signature despite near tumor clearance, resulting in hypercytokinemia and death. NFAT-inducible co-expression of tethered IL15/IL21 enhanced GPC2-CAR T-cell function against a high neuroblastoma burden with acceptable tolerability in mice. Further studies are required to validate these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
科研通AI6.3的应助被三块石头采纳,获得10
2秒前
南风向北完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
3秒前
梦寐完成签到,获得积分10
3秒前
Eourique发布了新的文献求助10
5秒前
今后的应助被zrl采纳,获得30
5秒前
Lucas的应助被俭朴灵竹采纳,获得10
6秒前
科研通AI6.4的应助被77采纳,获得10
6秒前
古德猫宁发布了新的文献求助10
6秒前
LG发布了新的文献求助10
7秒前
星辰大海的应助被文2026采纳,获得10
7秒前
打打的应助被倾解采纳,获得30
8秒前
飘逸小之发布了新的文献求助10
9秒前
10秒前
10秒前
13秒前
14秒前
整齐半青完成签到 ,获得积分10
15秒前
反反复复发布了新的文献求助10
15秒前
16秒前
16秒前
充电宝的应助被ddl30采纳,获得10
17秒前
ForTune发布了新的文献求助10
17秒前
punch发布了新的文献求助20
18秒前
暖柚完成签到,获得积分10
18秒前
至一完成签到,获得积分10
18秒前
舒适剑发布了新的文献求助10
19秒前
19秒前
不知道叫什么完成签到 ,获得积分10
21秒前
21秒前
春风暮雪发布了新的文献求助10
22秒前
syvshc的应助被洋芋二号采纳,获得10
22秒前
刘辞忧发布了新的文献求助10
22秒前
Lucas的应助被香蕉灵采纳,获得20
22秒前
bkagyin的应助被夏侯乌采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184646
求助须知:如何正确求助?哪些是违规求助? 9573637
关于积分的说明 21832477
捐赠科研通 7781914
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558498
邀请新用户注册赠送积分活动 2481003